Advanced Enzyme Technologies (NSE:ADVENZYMES) Total Operating Expense: ₹3,638 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ADVENZYMES Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
89 GF Score
Price ₹324.35
GF Value ₹420.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Advanced Enzyme Technologies Total Operating Expense?

Advanced Enzyme Technologies NSE:ADVENZYMES -1.65% 89 Total Operating Expense is ₹3,638 Mil as of Mar. 2026. GuruFocus rates NSE:ADVENZYMES with a GF Score™ of 89/100 and a GF Value™ of ₹420.89 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Advanced Enzyme Technologies's Total Operating Expense for the three months ended in Mar. 2026 was ₹934 Mil. Advanced Enzyme Technologies's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,638 Mil.

Advanced Enzyme Technologies Total Operating Expense Related Terms

Advanced Enzyme Technologies Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Advanced Enzyme Technologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Enzyme Technologies Total Operating Expense Chart

Advanced Enzyme Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,409.09 2,593.18 2,912.38 3,110.86 3,459.06

Advanced Enzyme Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 855.66 890.51 899.82 913.99 934.01
NSE:ADVENZYMES
89GF Score
Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Enzyme Technologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,638 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹3,638 Mil mean?
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a Total Operating Expense of ₹3,638 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Advanced Enzyme Technologies and its competitors.
Is Advanced Enzyme Technologies' Total Operating Expense too high?
Advanced Enzyme Technologies' current Total Operating Expense is ₹3,638 Mil. Overall, Advanced Enzyme Technologies has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' Total Operating Expense compare to LIN and SHW?
Advanced Enzyme Technologies' Total Operating Expense of ₹3,638 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Chemicals company?
A good Total Operating Expense depends on the Chemicals industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Advanced Enzyme Technologies and its competitors. Advanced Enzyme Technologies's current Total Operating Expense is ₹3,638 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.89, compared to a current price of ₹324.35 — trading 22.9% below its estimated fair value. The current Total Operating Expense is ₹3,638 Mil. Advanced Enzyme Technologies' overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current Total Operating Expense is ₹3,638 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued. The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89. GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.

Key valuation signals for NSE:ADVENZYMES:

  • Total Operating Expense: ₹3,638 Mil
  • GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advanced Enzyme Technologies Business Description

Other Exchanges 540025:India
Address Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score

Get the complete analysis for NSE:ADVENZYMES

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹324.35
Price
₹420.89
GF Value